RAS Peptide Cancer Vaccine

Preferred Label : RAS Peptide Cancer Vaccine;

NCIt definition : A cancer vaccine containing a RAS oncogene-encoded peptide with potential antineoplastic activity. RAS peptide cancer vaccine may stimulate a RAS peptide-specific antitumoral T-cell cytotoxic immune response, resulting in an inhibition of tumor cell proliferation and tumor cell death. (NCI04);

Details

Origin ID

C2438;

UMLS CUI

C0677674;

Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_has_mechanism_of_action
- Antigen Sensitization [NCIt concept]
concept_is_in_subset
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
is_component_of_chemotherapy_regimen
- Detox-B Adjuvant/RAS Peptide Cancer Vaccine [NCIt concept]
- Detoxpc/Interleukin-2/RAS Peptide Cancer Vaccine/Sargramostim [NCIt concept]
- Interleukin-2/Ras Peptide Cancer Vaccine [NCIt concept]
- QS21/RAS peptide cancer vaccine [NCIt concept]
- RAS Peptide Cancer Vaccine/Sargramostim [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients